Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤6 brain metastases: A multi-institutional phase II trial

Journal of Neuro-Oncology

Volumn 105, Issue 2, 2011, Pages 301-308

  McHaffie, Derek R ^a   Chabot, Pierre ^b   Dagnault, Anne ^c   Suh, John H ^d   Fortin, Marie Andrée ^e   Chang, Eric ^f   Timmerman, Robert ^g   Souhami, Luis ^h   Grecula, John ⁱ   Nabid, Abdenour ^j   Schultz, Chris ^k   Werner Wasik, Maria ^l   Gaspar, Laurie E ^m   Brachman, David ⁿ   Mody, Tarak ^o   Mehta, Minesh P ^p  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d LERNER RESEARCH INSTITUTE   (United States)

^e NOTRE DAME HOSPITAL   (Canada)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h MCGILL UNIVERSITY   (Canada)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^k MEDICAL COLLEGE OF WISCONSIN   (United States)

^l THOMAS JEFFERSON UNIVERSITY   (United States)

^m UNIVERSITY OF COLORADO   (United States)

ⁿ ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^o PHARMACYCLICS INC   (United States)

^p NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

Brain metastases; Motexafin gadolinium; Stereotactic radiosurgery; Whole brain radiotherapy

Indexed keywords

GADOLINIUM TEXAPHYRIN;

ADULT; AGED; ANEMIA; ARTHRALGIA; ARTICLE; BLISTER; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DERMATITIS; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXFOLIATIVE DERMATITIS; FATIGUE; FEASIBILITY STUDY; FEMALE; HEADACHE; HEART ATRIUM FIBRILLATION; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROLOGIC DISEASE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION NECROSIS; RASH; SIDE EFFECT; SKIN ALLERGY; SKIN DISCOLORATION; SKIN TOXICITY; STEREOTACTIC RADIOSURGERY; TREATMENT PLANNING; WEAKNESS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL AGENCIES; MALE; METALLOPORPHYRINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; RADIOSURGERY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 82955233755     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0590-9     Document Type: Article

References (31)

1. P Richards KW Mc 1963 Intracranial metastases Br Med J 1 15 18 13982100 10.1136/bmj.1.5322.15 1:STN:280:DyaF387ntl2htw%3D%3D
2. EF Lang J Slater 1964 Metastatic brain tumors. Results of surgical and nonsurgical treatment Surg Clin North Am 44 865 872 14184441 1:STN:280:DyaF2c7kt1ClsQ%3D%3D
3. B Borgelt R Gelber S Kramer, et al. 1980 The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 6 1 9 6154024 1:STN:280: DyaL3c7lvFekuw%3D%3D (Pubitemid 10103009)
4. D Kondziolka A Patel LD Lunsford, et al. 1999 Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases Int J Radiat Oncol Biol Phys 45 427 434 10487566 1:STN:280:DyaK1MvhsFGjtQ%3D%3D (Pubitemid 29408559)
5. DW Andrews CB Scott PW Sperduto, et al. 2004 Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Lancet 363 1665 1672 15158627 10.1016/S0140-6736(04)16250-8 (Pubitemid 38670323)
6. AK Bhatnagar JC Flickinger D Kondziolka, et al. 2006 Stereotactic radiosurgery for four or more intracranial metastases Int J Radiat Oncol Biol Phys 64 898 903 16338097 10.1016/j.ijrobp.2005.08.035 (Pubitemid 43183591)
7. F Zahedi Avval C Berndt A Pramanik, et al. 2009 Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd) Biochem Biophys Res Commun 379 775 779 19121624 10.1016/j.bbrc.2008.12.128 1:CAS:528: DC%2BD1MXhtFemtL8%3D
8. SI Hashemy JS Ungerstedt F Zahedi Avval, et al. 2006 Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase J Biol Chem 281 10691 106977 16481328 10.1074/jbc.M511373200 1:CAS:528:DC%2BD28XjsFSqtbo%3D (Pubitemid 43855490)
9. D Magda P Lecane RA Miller, et al. 2005 Motexafin gadolinium disrupts zinc metabolism in human cancer cell lines Cancer Res 65 3837 3845 15867382 10.1158/0008-5472.CAN-04-4099 1:CAS:528:DC%2BD2MXjslGks7o%3D (Pubitemid 40616364)
10. RJ Amato J Jac J Hernandez-McClain 2008 Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results Clin Genitourin Cancer 6 73 78 18824428 10.3816/CGC.2008.n.011 1:CAS:528: DC%2BD1cXhtlWnurzP
11. PS Lecane MW Karaman M Sirisawad, et al. 2005 Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines Cancer Res 65 11676 11688 16357179 10.1158/0008-5472.CAN-05-2754 1:CAS:528:DC%2BD2MXhtlWiu7vN (Pubitemid 41821728)
12. D Magda C Lepp N Gerasimchuk, et al. 2001 Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species Int J Radiat Oncol Biol Phys 51 1025 1036 11704327 10.1016/S0360-3016(01)01810-7 1:CAS:528:DC%2BD3MXotFWjtrk%3D (Pubitemid 33026434)
13. RA Miller K Woodburn Q Fan, et al. 1999 In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer Int J Radiat Oncol Biol Phys 45 981 989 10571206 10.1016/S0360-3016(99)00274-6 1:CAS:528:DyaK1MXntleksr4%3D (Pubitemid 29525463)
14. RA Miller KW Woodburn Q Fan, et al. 2001 Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin Clin Cancer Res 7 3215 3221 11595717 1:CAS:528:DC%2BD3MXnvF2rs74%3D (Pubitemid 32963846)
15. S Xu K Zakian H Thaler, et al. 2001 Effects of Motexafin gadolinium on tumor metabolism and radiation sensitivity Int J Radiat Oncol Biol Phys 49 1381 1390 11286846 10.1016/S0360-3016(00)01566-2 1:CAS:528:DC%2BD3MXisVWnt74%3D (Pubitemid 32294318)
16. G Bepler Z Zheng A Gautam, et al. 2005 Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance Lung Cancer 47 183 192 15639717 10.1016/j.lungcan.2004.07.043 (Pubitemid 40082161)
17. DI Rosenthal P Nurenberg CR Becerra, et al. 1999 A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging Clin Cancer Res 5 739 745 10213207 1:CAS:528:DyaK1MXislOnsL4%3D (Pubitemid 29180823)
18. J Viala D Vanel P Meingan, et al. 1999 Phases IB and II multidose trial of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging: preliminary results in brain metastases Radiology 212 755 759 10478243 1:CAS:528:DyaK1MXmtV2ktLk%3D (Pubitemid 29410979)
19. MP Mehta WR Shapiro SC Phan, et al. 2008 Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial Int J Radiat Oncol Biol Phys 73 1069 1076 18977094 10.1016/j.ijrobp.2008.05.068
20. World Medical Association Declaration of Helsinki 2001 Ethical principles for medical research involving human subjects Bull World Health Organ 79 373 374
21. E Shaw C Scott L Souhami, et al. 2000 Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05 Int J Radiat Oncol Biol Phys 47 291 298 10802351 10.1016/S0360-3016(99)00507-6 1:STN:280:DC%2BD3c3mtlyjuw%3D%3D (Pubitemid 30236367)
22. L Gaspar C Scott M Rotman, et al. 1997 Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 745 751 9128946 10.1016/S0360-3016(96)00619-0 1:STN:280:DyaK2s3nsFSmsA%3D%3D (Pubitemid 27181303)
23. H Aoyama H Shirato M Tago, et al. 2006 Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial JAMA 295 2483 2491 16757720 10.1001/jama.295.21.2483 1:CAS:528:DC%2BD28XlsV2ltbo%3D (Pubitemid 43854963)
24. KA Bradley IF Pollack JM Reid, et al. 2008 Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study Neuro Oncol 10 752 758 18715950 10.1215/15228517-2008-043 1:CAS:528:DC%2BD1cXht1GqsrzN
25. JM Ford W Seiferheld JR Alger, et al. 2007 Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme Int J Radiat Oncol Biol Phys 69 831 838 17560737 10.1016/j.ijrobp.2007.04.017 1:CAS:528:DC%2BD2sXhtVOitrbE (Pubitemid 47418404)
26. WN William Jr RG Zinner DD Karp, et al. 2007 Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer J Thorac Oncol 2 745 750 17762342 10.1097/JTO.0b013e31811f4719 (Pubitemid 47357530)
27. MP Mehta P Rodrigus CH Terhaard, et al. 2003 Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases J Clin Oncol 21 2529 2536 12829672 10.1200/JCO.2003.12.122 1:CAS:528:DC%2BD2cXptlCkt78%3D (Pubitemid 46606335)
28. EL Chang JS Wefel KR Hess, et al. 2009 Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial Lancet 10 1037 1044 10.1016/S1470-2045(09)70263-3
29. J Li SM Bentzen M Renschler, et al. 2007 Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function J Clin Oncol 25 1260 1266 17401015 10.1200/JCO.2006.09. 2536 (Pubitemid 46640573)
30. H Aoyama M Tago N Kato, et al. 2007 Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone Int J Radiat Oncol Biol Phys 68 1388 1395 17674975 10.1016/j.ijrobp.2007.03.048 (Pubitemid 47176822)
31. GN Wu JM Ford JR Alger 2003 MRI measurement of the uptake and retention of motexafin gadolinium in glioblastoma multiforme and uninvolved normal human brain J Neurooncol 77 95 103 10.1007/s11060-005-9101-1 (Pubitemid 43870567)